Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million
Published 1 week, 6 days ago
Description
ANI Pharmaceuticals makes an offer to acquire Egetis Therapeutics as Egetis separately sells its priority review voucher for $190 million, Novartis exits its BrainTransporter deal with BioArctic 14 months after signing, and Ignite Proteomics’ Dr. Brian Corgiat on improving how tumors are tested after recurrence.